Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials
Cancer Letters · 2023-09 · 571 · 216348
DOI: 10.1016/j.canlet.2023.216348 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2023-09. Verfasst von Zixin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 165 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission, Program of Shanghai Academic Research Leader.
Abstract (Originalsprache)
Copper is a necessary cofactor vital for maintaining biological functions, as well as participating in the development of cancer. A plethora of studies have demonstrated that copper is a double-edged sword, presenting both benefits and detriments to tumors. The liver is a metabolically active organ, and an imbalance of copper homeostasis can result in deleterious consequences to the liver. Hepatocellular carcinoma (HCC), the most common primary liver cancer, is a highly aggressive malignancy with limited viable therapeutic options. As research advances, the focus has shifted towards the relationships between copper and HCC. Innovatively, cuproplasia and cuproptosis have been proposed to depict copper-related cellular growth and death, providing new insights for HCC treatment. By summarizing the constantly elucidated molecular connections, this review discusses the mechanisms of copper in the pathogenesis, progression, and potential therapeutics of HCC. Additionally, we aim to tentatively provide a theoretical foundation and gospel for HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China; International Co-operation Laboratory on…
- International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Second Military Medical University, Shanghai, 200438, China; National Center for Liver Cancer, Second Milit…
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Program of Shanghai Academic Research Leader
Zitieren
APA
Wu, Z., Lv, G., Xing, F., Xiang, W., Ma, Y., Feng, Q., Yang, W., & Wang, H. (2023). Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials. Cancer Letters, 571, 216348. https://doi.org/10.1016/j.canlet.2023.216348
Vancouver
Wu Z, Lv G, Xing F, Xiang W, Ma Y, Feng Q, et al. Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials. Cancer Letters. 2023;571:216348. doi:10.1016/j.canlet.2023.216348
BibTeX
@article{Wu2023,
author = {Wu, Zixin and Lv, Guishuai and Xing, Fuxue and Xiang, Wei and Ma, Yue and Feng, Qiyu and Yang, Wen and Wang, Hongyang},
title = {Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials},
journal = {Cancer Letters},
year = {2023},
volume = {571},
pages = {216348},
doi = {10.1016/j.canlet.2023.216348}
}
EUVIMED